↓ Skip to main content

Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials

Overview of attention for article published in Frontiers in Molecular Biosciences, September 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials
Published in
Frontiers in Molecular Biosciences, September 2022
DOI 10.3389/fmolb.2022.930361
Pubmed ID
Authors

Marco Invernizzi, Lorenzo Lippi, Arianna Folli, Alessio Turco, Lorenzo Zattoni, Antonio Maconi, Alessandro de Sire, Nicola Fusco

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 9%
Student > Master 3 7%
Student > Bachelor 2 5%
Student > Doctoral Student 2 5%
Unspecified 2 5%
Other 6 14%
Unknown 25 57%
Readers by discipline Count As %
Nursing and Health Professions 9 20%
Unspecified 2 5%
Sports and Recreations 2 5%
Mathematics 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 2 5%
Unknown 27 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2022.
All research outputs
#20,864,077
of 23,479,361 outputs
Outputs from Frontiers in Molecular Biosciences
#2,703
of 4,077 outputs
Outputs of similar age
#345,170
of 433,242 outputs
Outputs of similar age from Frontiers in Molecular Biosciences
#219
of 399 outputs
Altmetric has tracked 23,479,361 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,077 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,242 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 399 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.